Uribel Tabs Tablet, Coated
NDC Package 0178-0745-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Uribel Tabs (methenamine, benzoic acid, phenyl salicylate, methylene blue, and hyoscyamine sulfate) tablets is uribel Tabs are indicated for the treatment of symptoms of irritative voiding. This formulation utilizes a tablet, coated delivery system. Marketed by Mission Pharmacal Company, this product is identified by NDC 0178-0745.

Identification & Billing

NDC Package Code
0178-0745-01
Package Description
100 TABLET, COATED in 1 BOTTLE
Product Code
0178-0745
11-Digit Billing Format
00178074501
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 1037234 - methenamine 81.6 MG / phenyl salicylate 36.2 MG / methylene blue 10.8 MG / benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG Oral Tablet
  • RxCUI: 1037234 - benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet
  • RxCUI: 2670308 - Uribel Tabs 81.6 MG / 9 MG / 36.2 MG / 10.8 MG / 0.12 MG Oral Tablet
  • RxCUI: 2670308 - benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet [Uribel Tabs]
  • RxCUI: 2670308 - Uribel Tabs (benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG) Oral Tablet

Clinical Specifications

Proprietary Name
Uribel Tabs
Non-Proprietary Name
Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate
Substance Name
Benzoic Acid; Hyoscyamine Sulfate; Methenamine; Methylene Blue; Phenyl Salicylate
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Uribel Tabs are indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.

Regulatory & Marketing

Labeler Name
Mission Pharmacal Company
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
11-07-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0178-0745-01 identifies a specific commercial package of 100 tablet, coated in 1 bottle of Uribel Tabs, a human prescription drug labeled by Mission Pharmacal Company. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet, coated is formulated for oral use and contains benzoic acid; hyoscyamine sulfate; methenamine; methylene blue; phenyl salicylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mission Pharmacal Company on November 07, 2023. The current certification is valid through December 31, 2027.

How is this Mission Pharmacal Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00178074501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0178-0745-01
11-Digit CMS (5-4-2)
00178-0745-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.